Aytu Biopharma (AYTU) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Aytu Biopharma (AYTU) over the last 6 years, with Q4 2025 value amounting to -$1.05.
- Aytu Biopharma's EPS (Weighted Average and Diluted) fell 27500.0% to -$1.05 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.2, marking a year-over-year decrease of 3483.15%. This contributed to the annual value of -$5.14 for FY2023, which is 9305.06% up from last year.
- As of Q4 2025, Aytu Biopharma's EPS (Weighted Average and Diluted) stood at -$1.05, which was down 27500.0% from -$0.08 recorded in Q3 2025.
- In the past 5 years, Aytu Biopharma's EPS (Weighted Average and Diluted) registered a high of $0.21 during Q1 2025, and its lowest value of -$35.9 during Q1 2022.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$4.91, with a median of -$1.08 in 2021.
- In the last 5 years, Aytu Biopharma's EPS (Weighted Average and Diluted) tumbled by 611714.29% in 2021 and then soared by 14038.46% in 2025.
- Quarter analysis of 5 years shows Aytu Biopharma's EPS (Weighted Average and Diluted) stood at -$8.74 in 2021, then surged by 75.38% to -$2.15 in 2022, then soared by 105.11% to $0.11 in 2023, then tumbled by 354.55% to -$0.28 in 2024, then tumbled by 275.0% to -$1.05 in 2025.
- Its EPS (Weighted Average and Diluted) was -$1.05 in Q4 2025, compared to -$0.08 in Q3 2025 and $0.21 in Q1 2025.